Pegaspargase (S95014)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegaspargase (S95014), covering 2023-07-05 to 2023-07-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL) [Phase 2]